Role of Raman spectroscopy and surface enhanced Raman spectroscopy in colorectal cancer
Open Access
- 1 January 2016
- journal article
- review article
- Published by Baishideng Publishing Group Inc. in World Journal of Gastrointestinal Oncology
- Vol. 8 (5) , 427-438
Abstract
Colorectal cancer (CRC) is the fourth most common cancer in the United Kingdom and is the second largest cause of cancer related death in the United Kingdom after lung cancer. Currently in the United Kingdom there is not a diagnostic test that has sufficient differentiation between patients with cancer and those without cancer so the current referral system relies on symptomatic presentation in a primary care setting. Raman spectroscopy and surface enhanced Raman spectroscopy (SERS) are forms of vibrational spectroscopy that offer a non-destructive method to gain molecular information about biological samples. The techniques offer a wide range of applications from in vivo or in vitro diagnostics using endoscopic probes, to the use of micro-spectrometers for analysis of biofluids. The techniques have the potential to detect molecular changes prior to any morphological changes occurring in the tissue and therefore could offer many possibilities to aid the detection of CRC. The purpose of this review is to look at the current state of diagnostic technology in the United Kingdom. The development of Raman spectroscopy and SERS in clinical applications relation for CRC will then be discussed. Finally, future areas of research of Raman/SERS as a clinical tool for the diagnosis of CRC are also discussed.Keywords
This publication has 56 references indexed in Scilit:
- Anti-CEA loaded maghemite nanoparticles as a theragnostic device for colorectal cancerInternational Journal of Nanomedicine, 2012
- Outcomes of the Bowel Cancer Screening Programme (BCSP) in England after the first 1 million testsGut, 2011
- Immunoassay for LMP1 in nasopharyngeal tissue based on surface-enhanced Raman scatteringInternational Journal of Nanomedicine, 2011
- The diagnostic value of symptoms for colorectal cancer in primary care: a systematic reviewBritish Journal of General Practice, 2011
- Comparison of Guaiac-Based and Quantitative Immunochemical Fecal Occult Blood Testing in a Population at Average Risk Undergoing Colorectal Cancer ScreeningAmerican Journal of Gastroenterology, 2010
- Once-only flexible sigmoidoscopy screening in prevention of colorectal cancer: a multicentre randomised controlled trialThe Lancet, 2010
- Potential for Raman spectroscopy to provide cancer screening using a peripheral blood sampleHead & Neck Oncology, 2009
- Surface-Enhanced Raman Scattering Tags for Rapid and Homogeneous Detection of Circulating Tumor Cells in the Presence of Human Whole BloodJournal of the American Chemical Society, 2008
- Tumour M2-PK as a stool marker for colorectal cancer: comparative analysis in a large sample of unselected older adults vs colorectal cancer patientsBritish Journal of Cancer, 2007
- The mortality of colorectal cancer in relation to the initial symptom at presentation to primary care and to the duration of symptoms: a cohort study using medical recordsBritish Journal of Cancer, 2006